首页> 外国专利> Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host

Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host

机译:疟疾前红细胞抗原作为融合多肽及其在宿主中引发保护性免疫应答的用途

摘要

The invention relates to chimeric Plasmodium antigenic polypeptides derived from pre-erythrocytic (PE) antigens and associated in a fusion polypeptide. In particular, the invention relates to antigenic fusion polypeptides of malaria parasites wherein said antigenic polypeptides exhibit a protective effect, especially that of eliciting a protective immune response in a host against challenge by Plasmodium sporozoites or a sterile response. Such identified antigenic fusion polypeptides may thus constitute active ingredients suitable for the design of a vaccine candidate, in particular a vaccine suitable for a human host.
机译:本发明涉及衍生自红细胞(PE)抗原和融合多肽的抗原多肽和抗原多肽的嵌合性抗原多肽。特别地,本发明涉及疟疾寄生虫的抗原融合多肽,其中所述抗原多肽表现出保护作用,特别是在宿主中引发保护性免疫应答,以通过疟原虫孢状体或无菌反应引起攻击。因此,这种鉴定的抗原融合多肽可以构成适于设计疫苗候选的活性成分,特别是适于人宿主的疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号